Health Care

Comments to WHO on Tobacco Harm-Reduction Products

May 16, 2018

World Health Organization
Independent High-Level Commission
On Non-Communicable Diseases

Re: Comments on May 1, 2018, First Draft Report

Citizens Against Government Waste (CAGW) appreciates the opportunity to comment on the World Health Organization’s (WHO) Independent High-Level Commission’s on Non-Communicable Diseases (NCDs) May 1, 2018, First Draft Report.

NAFTA Negotiators Should Promote Strong IP Rights

As the May 18 deadline for negotiating a modernized North American Free Trade Agreement (NAFTA) looms, negotiators should consider closely how intellectual property (IP) rights will be treated between the countries involved.

President Trump's Drug Costs Proposals Coming Soon

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

FDA Study on BPA: Nothing's Changed Since February

You may recall a March 5, WasteWatcher blog, “New FDA Report on BPA: It is Still Safe,” which discussed a pre-peer review draft study released by the National Toxicology Program (NTP) on bisphenol A (BPA), a compound used to produce plastic products and epoxy resins used in food and beverage can linings.  The study, two-years in length and the largest ever conducted on BPA, took place at the Food and Drug Administration’s (FDA) National Center for Toxicological Research (NCTR).

Citizens Against Government Waste Highlights GAO Duplication Report

(Washington, D.C.) – Citizens Against Government Waste (CAGW) highlighted the release of the Government Accountability Office’s (GAO) eighth annual report on, “Additional Opportunities to Reduce Fragmentation, Overlap, and Duplication and Achieve Other Financial Benefits.”

The Fourth Circuit Was Right to Reject Price Controls for Generic Drugs

This prudent decision will send a strong message to other state legislatures across the country not to pursue similar legislation.

Obamacare is Bringing BIG Changes

The Patient Protection and Affordable Care Act, or Obamacare, is bringing many changes in the healthcare space and few are as subtly transformative as the rapid increase in cross-industry consolidation.  A record breaking 115 mergers and acquisitions among hospitals and health systems occurred in 2017, an increase of 13 percent from 2016.

Stealing Patents Won’t Bring Down Drug Costs

On February 15, 2018, 18 Democratic members of Congress sent a letter to Health and Human Services (HHS) Secretary Alex Azar, asking him to use his authority under 28 U.S.C.

A Moment of Truth: Will Virginia Republicans Expand Medicaid?

On April 11, 2018, Virginia legislators will return to Richmond for a special session in which they will aim to finish work on the Commonwealth’s budget.  At center stage, yet again, is the issue of Medicaid expansion, still unresolved eight years after Obamacare became law.

Comments to FDA on Modified Risk Tobacco Product Applications

March 21, 2018

Commissioner Scott Gottlieb, M.D.
Food and Drug Administration
Dockets Management Staff
HFA-305
5630 Fishers Lane
Room 1061
Rockville, Maryland  20852

Attention

Docket Number FDA-2017-D-3001
Modified Risk Tobacco Product Applications (MRTPA) by Philip Morris Products S.A. Applications for IQOS system with Marlboro Heatsticks, IQOS system with Marlboro Smooth Menthol Heatsticks, and IQOS system with Marlboro Fresh Menthol Heatsticks

Pages

Sign Up for Email Updates!Click Here!

CAGW Names Washington, D.C. Mayor Muriel Bowser April 2018 Porker of the Month

Mayor Bowser is CAGW's Porker of the Month for attempting to bail out the failing Washington Metrorail system by taxing Uber and Lyft riders.